Newborn Screening and Early Treatment for Rare Genetic Disorder, LA BioMed Reveals

Published: Dec 29, 2010

(Ivanhoe Newswire) – Researchers believe that newborn screening and early treatment for a rare genetic disorder, mucopolysaccharidosis type I (MPS I), is needed so that enzyme replacement therapy can begin at birth and eliminate all the symptoms associated with MPS I.

Back to news